Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Detection of LGD‐4033 and its metabolites in athlete urine samples
Holly D. Cox, Daniel Eichner
Drug Testing and Analysis (2016) Vol. 9, Iss. 1, pp. 127-134
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Detection of SARMs in doping control analysis
Mario Thevis, Wilhelm Schänzer
Molecular and Cellular Endocrinology (2017) Vol. 464, pp. 34-45
Closed Access | Times Cited: 74
Analytical Approaches in Human Sports Drug Testing: Recent Advances, Challenges, and Solutions
Mario Thevis, Katja Walpurgis, Andreas Thomas
Analytical Chemistry (2019) Vol. 92, Iss. 1, pp. 506-523
Closed Access | Times Cited: 49
Human in vivo metabolism study of LGD‐4033
Argyro G. Fragkaki, P. Sakellariou, Polyxeni Kiousi, et al.
Drug Testing and Analysis (2018) Vol. 10, Iss. 11-12, pp. 1635-1645
Closed Access | Times Cited: 39
Considerations, possible contraindications, and potential mechanisms for deleterious effect in recreational and athletic use of selective androgen receptor modulators (SARMs) in lieu of anabolic androgenic steroids: A narrative review
Steven B. Machek, Thomas D. Cardaci, Dylan T. Wilburn, et al.
Steroids (2020) Vol. 164, pp. 108753-108753
Closed Access | Times Cited: 33
Selective androgen receptor modulator use and related adverse events including drug-induced liver injury: Analysis of suspected cases
Natalia Leciejewska, Karol Jędrejko, Víctor Manuel Gómez Renaud, et al.
European Journal of Clinical Pharmacology (2023) Vol. 80, Iss. 2, pp. 185-202
Open Access | Times Cited: 11
Investigation of the metabolism of the selective androgen receptor modulator LGD‐4033 in equine urine, plasma and hair following oral administration
Charlotte Cutler, Marjaana Viljanto, Pamela Hincks, et al.
Drug Testing and Analysis (2019) Vol. 12, Iss. 2, pp. 247-260
Closed Access | Times Cited: 32
Investigation of in vitro generated metabolites of GLPG0492 using equine liver microsomes for doping control
Tajudheen K. Karatt, M. Anwar Sathiq, Saraswathy Laya, et al.
Drug Testing and Analysis (2023) Vol. 15, Iss. 6, pp. 605-628
Closed Access | Times Cited: 10
Detection of LGD‐4033 Metabolites in Camel Urine, Plasma, and Hair Following Oral Administration for Doping Control
Praseen Ondern Komathu, Syed Ali M Padusha, Laya Saraswathy, et al.
Rapid Communications in Mass Spectrometry (2025) Vol. 39, Iss. 8
Closed Access
Development and validation of a semi-quantitative ultra-high performance liquid chromatography-tandem mass spectrometry method for screening of selective androgen receptor modulators in urine
Emiliano Ventura, Anna Gadaj, Gail Monteith, et al.
Journal of Chromatography A (2019) Vol. 1600, pp. 183-196
Open Access | Times Cited: 28
Equine in vivo -derived metabolites of the SARM LGD-4033 and comparison with human and fungal metabolites
Annelie Hansson, Heather K. Knych, Scott D. Stanley, et al.
Journal of Chromatography B (2017) Vol. 1074-1075, pp. 91-98
Closed Access | Times Cited: 26
Investigations into the elimination profiles and metabolite ratios of micro-dosed selective androgen receptor modulator LGD-4033 for doping control purposes
Felicitas Wagener, Sven Guddat, Christian Görgens, et al.
Analytical and Bioanalytical Chemistry (2021) Vol. 414, Iss. 2, pp. 1151-1162
Open Access | Times Cited: 20
Mass spectrometry in sports drug testing—Analytical approaches and the athletes' exposome
Mario Thevis, Christian Görgens, Sven Guddat, et al.
Scandinavian Journal of Medicine and Science in Sports (2022) Vol. 34, Iss. 1
Open Access | Times Cited: 14
Annual banned‐substance review: Analytical approaches in human sports drug testing
Mario Thevis, Tiia Kuuranne, Hans Geyer
Drug Testing and Analysis (2017) Vol. 10, Iss. 1, pp. 9-27
Closed Access | Times Cited: 23
Recent advances in identifying and utilizing metabolites of selected doping agents in human sports drug testing
Mario Thevis, Thomas Piper, Andreas Thomas
Journal of Pharmaceutical and Biomedical Analysis (2021) Vol. 205, pp. 114312-114312
Closed Access | Times Cited: 18
Variation of Sequential Ligandrol (LGD-4033) Metabolite Levels in Routine Anti-Doping Urine Samples Detected with or without Other Xenobiotics
Dorota Kwiatkowska, Mariola Wicka, Krzysztof Grucza, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6486-6486
Open Access | Times Cited: 7
Mass spectrometric characterization of the selective androgen receptor modulator (SARM) YK‐11 for doping control purposes
Mario Thevis, Thomas Piper, Josef Dib, et al.
Rapid Communications in Mass Spectrometry (2017) Vol. 31, Iss. 14, pp. 1175-1183
Closed Access | Times Cited: 20
High‐throughput liquid chromatography tandem mass spectrometry assay as initial testing procedure for analysis of total urinary fraction
Tim Sobolevsky, Brian Ahrens
Drug Testing and Analysis (2020) Vol. 13, Iss. 2, pp. 283-298
Closed Access | Times Cited: 18
Detection of the selective androgen receptor modulator GSK2881078 and metabolites in urine and hair after single oral administration
Alina Rading, Patricia Anielski, Detlef Thieme, et al.
Drug Testing and Analysis (2020) Vol. 13, Iss. 1, pp. 217-222
Open Access | Times Cited: 17
Simultaneous detection of different chemical classes of selective androgen receptor modulators in urine by liquid chromatography-mass spectrometry-based techniques
Carlotta Stacchini, Francesco Botrè, Fabio Comunità, et al.
Journal of Pharmaceutical and Biomedical Analysis (2020) Vol. 195, pp. 113849-113849
Closed Access | Times Cited: 17
Metabolic study of selective androgen receptor modulator LY2452473 in thoroughbred horses for doping control
Tajudheen K. Karatt, M. Anwar Sathiq, Saraswathy Laya, et al.
Rapid Communications in Mass Spectrometry (2023) Vol. 37, Iss. 9
Closed Access | Times Cited: 6
Targeted Metabolic Investigation of Ligandrol and Analytical Methods Validation for Its Main Long‐term Metabolite
Yiannis S. Angelis, Panagiotis Sakellariou, Michael Petrou, et al.
ChemPlusChem (2024) Vol. 89, Iss. 5
Open Access | Times Cited: 2
Investigation of Equine In Vivo and In Vitro Derived Metabolites of the Selective Androgen Receptor Modulator (SARM) ACP-105 for Improved Doping Control
Malin Nilsson Broberg, Heather K. Knych, Ulf Bondesson, et al.
Metabolites (2021) Vol. 11, Iss. 2, pp. 85-85
Open Access | Times Cited: 13
Investigation of in vitro generated metabolites of LGD‐4033, a selective androgen receptor modulator, in homogenized camel liver for anti‐doping applications
Praseen Ondern Komathu, M. Syed Ali Padusha, Saraswathy Laya, et al.
Rapid Communications in Mass Spectrometry (2023) Vol. 37, Iss. 22
Open Access | Times Cited: 5
Analytical challenges in sports drug testing
Mario Thevis, Oliver Krug, Hans Geyer, et al.
Analytical and Bioanalytical Chemistry (2018) Vol. 410, Iss. 9, pp. 2275-2281
Closed Access | Times Cited: 16
Identification of equine in vitro metabolites of seven non‐steroidal selective androgen receptor modulators for doping control purposes
Charlotte Cutler, Marjaana Viljanto, Polly Taylor, et al.
Drug Testing and Analysis (2021) Vol. 14, Iss. 2, pp. 349-370
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top